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Objective: Interpreting a randomised trial requires access to more than the main results 
paper. We aimed to determine the: 1) proportion of trials referring to the protocol in the 
trial report and their accessibility; 2) proportion of protocols accessible from trial registry 
entry and by trial registration number search; and 3) types of additional publications 
associated with trial reports. 
Study Design and Setting: A previously-gathered sample of randomised trials of non-
pharmacological interventions published in 2009 was used. Trial reports and registry entries 
were searched for protocol mentions and obtained when possible. Related publications were 
identified using citation searching. 
Results: Of 133 trials, 96 (72%) mentioned the protocol within the report, 61 (64%) contained 
details about protocol acquisition, with 48 (36%) protocols obtainable. Of the 129 registered 
trials, 32 (25%) had protocols obtainable from registry entry. Citation tracking identified 1030 
related publications; secondary analyses and qualitative studies most common.  
Conclusion: Trial protocols facilitate good trial conduct and interpretation. However, they 
are often not linked to the main report or registry and can be difficult to obtain. Many trials 
have related publications which are inconsistently linked. Trial registries and registration 
numbers could facilitate the threading of articles related to a trial, but currently do not.  
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• Analysis of the linking of protocols to main trial reports and trial registry entries 
• Only one in three randomised trials had an obtainable protocol  
• Protocols obtainable from trial registry entry for only 25% of trials  
• Many randomised trials had numerous related publications, but they are 
inconsistently linked to the trial report 





Randomised controlled trials are the gold standard for estimating treatment effects as they 
are less susceptible to bias and confounding than other primary study designs [1]. Trials 
require substantial financial and non-financial resources and time to conduct. While 
publication of the results of a trial is typically in the form of a main results article in a 
journal, many trials generate multiple related publications. The concept of ‘linked or 
threaded publications’ was proposed by Chalmers and Altman [2] in 1999. It considers that 
the published main trial report is one element in a series of ‘threaded’ publications that link 
together the trial protocol, main results paper (the primary trial paper), and other related 
papers, such as commentaries, secondary analyses, economic/cost analyses, follow-up 
studies, and systematic reviews [3]. 
 
Awareness of these other linked publications by readers of a trial is low and there is 
difficulty accessing the additional publications that surround an individual trial [4]. All the 
related publications for a trial are rarely available from a single resource and locating them 
usually requires labour-intensive searching in multiple sources such as bibliographic 
databases, trial registries, author websites, and regulatory review reports [5]. When 
publications and complete trial details and data are not publicly available, trial authors need 
to be contacted – although this often does not produce a response or the required 
information [6].  
 
Good trial protocols are important for facilitating appropriate conduct and reporting of 
randomised trials, and their availability contributes to minimising research waste [7, 8]. 
[8].Protocols are not publicly available for many trials, but an estimate of the extent of this 
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has not been previously quantified. Arguably, the most potentially powerful strategy for 
linking trial protocols, trial reports, and other related publications is trial registration. 
However, this strategy appears to be grossly underutilised. Despite mandates by 
organisations, including the International Committee of Medical Journal Editors (ICMJE) 
requiring timely trial registration with an acceptable registry, [9] about half of trials are not 
registered [10]. Even for registered trials, it is uncommon for protocols or other related 
documents, to be provided as part of the registration process, with few trial registry systems 
requiring, checking, or even enabling upload of trial materials [11]. 
 
The aims of this study were to determine, in a sample of randomised trials of non-
pharmacological interventions: 1) the proportion of trials that referred to the trial protocol 
in the main trial report and accessibility of the protocols; 2) the proportion of trial protocols 
that could be obtained by searching using a trial’s registration number; and 3) the types of 




Search strategy and selection of trial reports  
A previously collected sample [6] of 133 screened and eligible randomised controlled trials 
of non-pharmacological interventions published in 2009 in one of the six leading general 
medical journals (based on ISI Web of Knowledge Impact Factor for 2010) – New England 
Journal of Medicine, the Journal of the American Medical Association, Lancet, Annals of 
Internal Medicine, PLOS Medicine, and the British Medical Journal, was used. This sample 
had been identified using a search of PubMed in April 2011, using the restrictions of year 
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(2009), publication type (‘randomised controlled trial’), and journal title (the six chosen 
journals). As part of the previous study [6], two researchers screened the 358 titles and 
abstracts retrieved, identified reports that might meet the inclusion criteria, and retrieved 
the full text (n = 133).  
 
Procedure for data collection  
For each trial, data were collected and recorded by one researcher (DS), in a data extraction 
form developed in Microsoft Excel. 
Trial protocols: To identify whether the trial report mentioned the trial protocol, text 
searching of the PDF, via search functionality, of each trial report was conducted. Text 
words searched for were: ‘protocol’, ’earlier’, ‘previous’, ’elsewhere’. If the protocol was 
mentioned, details were noted about where it was mentioned within the full-text, and 
details about how to access the protocol (such as a journal reference, URL, trial registry 
number, supplementary material, trial or author’s website, or by request from the author).  
Efforts were made to obtain the full text of the protocol of each trial, using the details 
provided in the trial report, and whether it could be obtained was recorded. The trial 
registry number and name of registry were obtained for all registered trials, the relevant 
trial registry was accessed, and the unique trial registry page for each trial was manually 
searched for a protocol (such as link to, reference to, or file upload). 
 
Additional publications related to the main trial: Two strategies were used by a medical 
librarian to identify additional publications, with these searches conducted between 
October 2018 and July 2019. Firstly, each trial’s registration number was searched in 
PubMed, all results found were imported into EndNote and labelled with the study identifier 
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of the original trial (first author’s surname and publication year), as well as the search 
method used to identify it (trial registry number search). Secondly, the title of each study 
was searched for and located in Scopus, then a backward and forward citation search for 
each trial was performed. 
 
All search results were grouped in EndNote by original trial report and one group was 
examined at a time to determine if the publication related to the original trial. Duplicates 
among each group were deleted and all search results were labelled with the original trial 
report and the search method used to find it (trial registry number, forward or backward 
citation). Any article from the forward and backward citation analysis that did not contain at 
least one of the authors from the main trial report was excluded. Where there were 10 or 
more authors, this was restricted to requiring only the first or senior (last) author to be 
listed, or in the case of large authorship group (>100 authors) trials, papers were examined 
if they had either one of the first ten authors or any of the last three authors. The abstract 
and full text of articles identified by this search process were examined by a researcher (DS), 
with discussion with an additional assessor (TH or JC) if needed. Articles assessed as being 
related to the main trial report were categorised into type of study.  
 
Results 
Reference to and accessibility of trial protocols  
Figure 1 shows the proportion of main trial reports that mentioned the trial protocol and 
whether the protocols could ultimately be obtained. Of the 133 trials, 96 (72.2%) mentioned 
the trial protocol within the main trial report. Of these 96, 61 (63.5%) contained details 
about how to obtain the protocol (such as a website, email to corresponding author, 
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reference, trial registry, or appendix/supplementary material). Forty-eight (78.7%) of these 
protocols were able to be obtained. Thirteen protocols were unable to be obtained due to 
non-functioning web links, insufficient location details provided, or non-response from 
authors who had advised that protocols were available upon email request. For the 133 
trials, 48 (36.1%) protocols were accessible.   
 
 
Figure 1. Flowchart showing the proportion of trials that mentioned a protocol and 
accessibility of the protocol 
 
Trial registry search results 
Of the 133 trials, 129 (97.0%) were registered, and 1 trial reported that it was exempt from 
registration. The majority (77, 59.7%) of these were registered in the Clinicaltrials.gov 
registry, 49 (38.0%) with the ISRCTN Registry, 2 with the Australian and New Zealand Clinical 
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Trials Registry, and 1 trial in the Chinese University of Hong Kong Clinical Trial Registry. Of 
the 129 registered trials, 32 (24.8%) had protocols accessible through their associated trial 
registry. Thirty of these were links to a citation in PubMed of the trial’s published protocol 
(published prior to publication of the main trial report). The other two protocols were 
obtained as a link to the protocol on the trial’s website was provided. None of these 
protocols were ones that were not also found by searching the main trial report. There was 
little difference between the main two registries in terms of protocol availability (ISRCTN n = 
14, Clinicaltrials.gov n = 18).  
 
Additional publications identified by forward and backward citation analysis  
The backwards and forwards citation search yielded a total of 4928 publications, of which 
1030 remained after removal of duplicates and deletion of trials not directly related to one 
of the 133 trials in our sample. Table 1 shows the number of additional studies located by 
the searching and the types of studies identified.  
 
Of the 1030 total additional studies located, across the 133 trial reports, 143 (13.8%) were 
published before the publication date of the main trial report and comprised of four study 
types: pilot studies or preliminary findings, protocols, qualitative studies, and economic 
analyses. Of the 887 additional publications detected in the forward citation search 
(published after the publication date of the main trial report), the three most common study 






n (%) found in 
backward 
citation search 
of N=143 total 
n (%) found in 
forward 
citation search 
of N=887 total 





Pilot study/preliminary findings 59 (41.3) 0 (0.0) 59 (5.7) 
Economic analysis 5 (3.5) 49 (5.5) 54 (5.2) 
Qualitative study 29 (20.3) 92 (10.4) 121 (11.7) 
Other quantitative analyses of 
trial data 0 (0.0) 607 (68.4) 607 (58.9) 
Systematic review 0 (0.0) 75 (8.5) 75 (7.3) 
(longer-term) follow-up results 
of main trial 0 (0.0) 62 (7.0) 62 (6.0) 
Trial protocol 50 (35.0) 0 (0.0) 50 (4.9) 
Other (e.g. consensus 
statement, correction for 
original trial) 0 (0.0) 2 (0.2) 2 (0.2) 
Total  143 (100.0) 887 (100.0) 1030 (100.0) 
 








This study aimed to assess the accessibility of trial protocols from the trial main report and 
trial registry, along with exploration of the types of additional publications that are 
associated with reports of trials of non-pharmacological interventions. A protocol could be 
obtained for about one-third of the trials in our sample, with more protocols obtainable 
using details within the published trial’s main report than in its registry entry. Most trials in 
our sample had a number of additional related publications, with subsequent quantitative 
analyses and qualitative studies being the most common types.  
 Although the majority of trials (72%) in our sample mentioned their protocol within 
the main trial report, protocols were only able to be obtained for just over one-third of the 
trials. Many trials mentioned the existence of a trial protocol, but insufficient detail about 
how and where to obtain the protocol was missing for about one-third of them. The most 
frequent and successful method for obtaining a trial’s protocol were from trials that had 
published their protocol and referenced it. Other methods were obtaining the protocol as 
part of the main trial report’s supplementary material, email to the author, and via a 
provided weblink. The latter two often did not work, with broken weblinks or no response 
from authors. As our sample of trials was from 2009 and this analysis occurred in 2019, over 
a 10-year period some weblinks and emails have changed or ceased to exist, and as such 
data shared via these methods are highly susceptible to becoming unavailable. 
Searching trial registry entries did not produce more protocols, with only one-
quarter of the trials having a protocol accessible (typically via a link to the published 
protocol) from the registry. Backwards citation searching found 50 study protocols, which is 
a similar proportion to the number of protocols found by searching the main trial reports. 
Ideally, all trials should make their protocol available (through either publication in a journal 
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and in the trial’s registry entry) and reference the protocol and its location in the main trial 
report.  
 The majority of publications found in the forwards citation search were other 
quantitative analyses of trial data. This presents an issue for unthreaded articles, as 
sometimes the results presented in other quantitative analyses of trial data can supplement 
earlier findings. For example, follow-up studies (with longer-term data) comprised 7% of the 
citations found by forward searching in our sample. If unthreaded to the original trial, data 
can easily be missed in syntheses. This can then confound subsequent syntheses such as 
systematic reviews. Our finding is similar to that of an analysis of a sample of 191 
randomised trials [12] which found that about half had a large number of secondary 
publications and that many of these had additional, and statistically significant, results. 
Cochrane groups have been tackling this issue with the use of study-based registers [13] in 
which a record that links related records to a single meta-record is created. This meta-
record then contains data tables with all the tabulated data from the multiple reports into a 
primary dataset [14]. Others, including publishers, have been attempting to tackle this issue 
by increasing the publication of study protocols, and working closely with both trial 
registries and databases to further develop existing infrastructure to capture the metadata 
about an article [3]. 
 The finding in our study of being able to obtain about one-third of protocols is 
similar to the finding of a meta-epidemiologic study [15] which compared the analysis plan 
in trial reports to the plan stated in the protocol and found that that 40% of protocols were 
accessible from a sample of 199 articles. Author response rate to email contact was 
approximately a third of those contacted, which is similar to other studies [12, 15], however 
in these studies, corresponding authors of all articles were contacted. The availability of 
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protocols does not seem to be improving over time, with an analysis of trials submitted to 
The Lancet in 2016 finding that only 95 (36%) of the 216 submissions had a protocol that 
was publicly available [16].  
Our study specifically looked at the accessibility of a trial protocol - this is important 
as there is evidence to suggest that selective reporting of outcomes occurs in randomised 
trials [17, 18] and this can be detected by comparing protocols to the main published trial 
report. These studies suggested the use of the trial registry as a means for facilitating 
protocol accessibility. However, our study found that only one-quarter of the trials had 
accessible protocols from the registry. The only obligation from ICMJE requirements is 
reporting of the trial registry ID in the article abstract when reporting trial outcomes [19]. 
This identifies the key issue with regards to a reference-based registry, where each citation 
acts individually, and unless a record contains a link somehow, such as via the trial registry 
number, additional citations do not appear as threaded within the registry [4].  
One of the study limitations is that our sample only contained trials of non-
pharmacological interventions and only trials from the top six leading general medical 
journals. These journals typically adhere more strictly to ICMJE requirements, such as 
requiring trial registration, than lower impact journals and hence our results may be an 
overestimate of the proportion of trials that have accessible protocols. Furthermore, trials 
in these journals are more likely to have generated a high number of forward citations of 
the original trial report [12]. This effect may overestimate the number of additional relevant 
publications that exist for trials. Exploration of the accessibility of protocols and additional 
relevant publications in a sample that includes trials of pharmacological interventions and 
those published in journals beyond the major general medical journals is needed. A further 
limitation is that our sample of trials was from 2009, and in subsequent  years there has 
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been increased awareness about the importance of study protocols as well as publication of 
the Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) reporting 
guideline [7]. However, as we were exploring trial-related papers that are published after 
the main trial report, there was also a need to ensure there was a reasonable number of 
years between the publication of the main trial reports and our search. Our study did not 
analyse the protocol to assess for discrepancies between the protocol content and the 
published data, and only one author searched trial registries and screened the search results 
for relevant additional publications.   
 
Conclusion 
Threaded publications for randomised trials, in which the study protocol is the often first 
element in a series of a threaded articles, followed by the main trial report and secondary 
publications, is not a new idea [2]. However, little progress towards achieving it appears to 
have occurred since the idea was first proposed, and the substantial fragmentation of 
publications related to a trial is a contributor to waste in research. Trial protocols are often 
not linked to, or mentioned in, the main trial report or its registry entry and can be difficult 
or impossible to obtain. Many trials have a number of related publications, but these are 
not consistently linked to the trial. Trial registries and registration numbers provide an 
opportunity to facilitate the threading process of articles linked to a randomised trial but are 
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